Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Radio Emissions Helmet Rapidly Detects Stroke

By HospiMedica International staff writers
Posted on 26 Apr 2018
A novel cerebral scanner detects asymmetry of intracranial fluids in patients undergoing a neurological assessment.

The Cerebrotech Medical (Pleasanton, CA, USA) Visor consists of a headband device with multiple integrated antennas that rapidly detect changes and distribution of cerebral fluids by broadcasting and receiving each other’s signals. More...
The technology, which is based on volumetric impedance phase-shift spectroscopy (VIPS), measures the ratio of bioimpedance between the brain's right and left hemispheres, and especially changes in that ratio. During severe stroke, a fluid asymmetry between hemispheres is formed; the greater the asymmetry, the more severe the stroke.

The small changes in intracranial fluids are reflected in the electrical properties of tissue, which can be calculated using several proprietary machine learning algorithms that can differentiate between the bioimpedance profiles of distinct brain pathologies, such as stroke, trauma, swelling, and others. In a study of 248 subjects across three cohorts, the Visor device differentiated between severe stroke and minor strokes with a sensitivity of 93%. The study was published on March 6, 2018, in the Journal of Neurointerventional Surgery.

“The thing that I like about this technology and this device is that it’s really easy to use. Instead of going through a checklist of stroke diagnosis and trying to analyze symptoms in the field, first responders can pop the visor on a patient’s head and secure a reading after 10 to 15 seconds,” said study co-author Raymond Turner, MD, a neurosurgeon at the Medical University of South Carolina (MUSC; Charleston, USA). “This is really taking the guessing game out of it. This is going to completely change how we triage stroke patients in the field.”

“We understand the challenges facing medical professionals who need to quickly assess patients with neurologic symptoms. The Cerebrotech Visor is designed to be portable, fast and accurate,” said Mitch Levinson, CEO of Cerebrotech Medical. “Utilizing the vast amount of data captured by our proprietary Cerebrotech Visor, our mission is to develop unique algorithms that can help physicians to better detect and diagnose a wide range of neurological conditions, improving outcomes for patients while reducing overall healthcare costs.”

Related Links:
Cerebrotech Medical


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gynecological Examination Chair
arco-matic
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.